Overview

Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba

Status:
Unknown status
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
Pityriasis alba (PA) is a common benign skin disorder, that usually affects children and adolescents of darker phototypes. A history of atopic dermatitis is a well-known risk factor, and PA may be a minor manifestation of atopic dermatitis, although it can occur in nonatopic individuals as well. The objective is to evaluate the effect of topical pimecrolimus in the treatment of treatment of PA
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
St Joseph University, Beirut, Lebanon
Treatments:
Pimecrolimus
Sunscreening Agents